COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 1056: Articles 10551-10560  | Next

Government messaging about COVID-19 vaccination in Canada and Australia: a Narrative Policy Framework study
Saich, F., Martiniuk, A.
10.1101/2021.12.19.21268042 — Posted: 2021-12-21
Passage of SARS-CoV-2 in cells expressing human and mouse ACE2 selects for mouse-adapted and ACE2-independent viruses
Yan, K., Dumenil, T., Le, T. T., Tang, B., Bishop, C., Suhrbier, A., Rawle, D. J.
10.1101/2021.12.16.473063 — Posted: 2021-12-21
Context-specific emergence and growth of the SARS-CoV-2 Delta variant
McCrone, J. T., Hill, V., Bajaj, S., Evans Pena, R., Lambert, B. C., Inward, R., Bhatt, S., Volz, E., Ruis, C., Dellicour, S., Baele, G., Zarebski, A. E., Sadilek, A., Wu, N., Schneider, A., Ji, X., Raghwani, J., Jackson, B., Colquhoun, R., O'Toole, A., Peacock, T. P., Twohig, K., Thelwall, S., Dabrera, G., Myers, R., The COVID-19 genomics UK (COG-UK) consortium, , Faria, N. R., Huber, C., Bogoch, I. I., Khan, K., Plessis, L. d., Barrett, J. C., Aanensen, D. M., Barclay, W. S., Chand, M., Connor, T., Loman, N. J., Suchard, M. A., Pybus, O. G., Rambaut, A., Kraemer, M. U. G.
10.1101/2021.12.14.21267606 — Posted: 2021-12-21
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammit, L. L., Suttcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S., Casadevall, A., Tobian, A. A., Hanley, D. F.
10.1101/2021.12.10.21267485 — Posted: 2021-12-21
Binding and Neutralizing Antibody Responses to SARS-CoV-2 in Infants and Young Children Exceed Those in Adults
Karron, R. A., Quesada, M. G., Schappell, E. A., Schmidt, S. D., Knoll, M. D., Hetrich, M. K., Veguilla, V., Doria-Rose, N., Dawood, F. S., SEARCh Study Team
10.1101/2021.12.20.21268034 — Posted: 2021-12-21
SARS-CoV-2 spike conformation determines plasma neutralizing activity
Bowen, J. E., Walls, A. C., Joshi, A., Sprouse, K. R., Stewart, C., Tortorici, M. A., Franko, N. M., Logue, J. K., Mazzitelli, I. G., Tiles, S. W., Ahmed, K., Shariq, A., Snell, G., Iqbal, N. T., Geffner, J., Bandera, A., Gori, A., Grifantini, R., Chu, H. Y., Van Voorhis, W. C., Corti, D., Veesler, D.
10.1101/2021.12.19.473391 — Posted: 2021-12-21
Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns
Rossotti, M. A., van Faassen, H., Tran, A., Sheff, J., Sandhu, J. A., Duque, D., Hewitt, M., Wen, S., Bavananthasivam, R., Beitari, S., Matte, K., Laroche, G., Giguere, P. M., Gervais, C., Stuible, M., Guimond, J., Perret, S., Hussack, G., Langlois, M.-A., Durocher, Y., Tanha, J.
10.1101/2021.12.20.473401 — Posted: 2021-12-21
The P3 O-Tert-Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors
Ma, Y., Yang, K., Geng, Z. Z., Alugubellia, Y. R., Shaabani, N., Vatansever, E. C., Ma, X. R., Cho, C.-C., Khatua, K., Blankenship, L., Yu, G., Sankaran, B., Li, P., Allen, R., Ji, H., Xu, S., Liu, W. R.
10.1101/2021.12.18.473326 — Posted: 2021-12-21
SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein-ACE2 Complex and Antibody Evasion
Mannar, D., Saville, J. W., Zhu, X., Srivastava, S. S., Berezuk, A. M., Tuttle, K., Marquez, C., Sekirov, I., Subramaniam, S.
10.1101/2021.12.19.473380 — Posted: 2021-12-21
Human genetic variants associated with COVID-19 severity are enriched in immune and epithelium regulatory networks
Feng, Z., Ren, X., Duren, Z., Wang, Y.
10.1101/2021.12.17.473140 — Posted: 2021-12-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).